http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2225022-C

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_12872c2cdd0696eb7ab790a29ce45082
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-02
filingDate 1997-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2008-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_76bd539d07c7445a64f3f7a918431382
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_188ad95a6c4fd43a4f97f4306c549fdc
publicationDate 2008-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2225022-C
titleOfInvention New polymorphous form of doxazosine mesylate (form iii)
abstract A new crystalline and anhydrous form of doxazosin mesylate of Formula I (see formula I) is described. The new form is crystalline and anhydrous and is characterised in its X-ray spectrum by the following reflex positions of high and medium intensity: 8.49° 21.03° 11.72° 22.87° 16.03° 25.02° 18.29° Owing to its crystalline properties, the new form of doxazosin mesylate according to the invention has surprising advantages both with regard to its synthesis and for pharmaceutical processing into solid dosage forms. A process for preparing the new form of doxazosin mesylate and medicaments containing the new form of doxazosin mesylate are also described.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8383627-B2
priorityDate 1996-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID180
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415809126
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453604874
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3157
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453343347
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409343598
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4893
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44383
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406903349
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406903350
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6395
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID657274
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419493489
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449826808
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407378349
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID175
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID103689
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537701
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25137856
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504078

Total number of triples: 48.